Structure of the catalytic domain of the colistin resistance enzyme MCR-1

BACKGROUND: Due to the paucity of novel antibiotics, colistin has become a last resort antibiotic for treating multidrug resistant bacteria. Colistin acts by binding the lipid A component of lipopolysaccharides and subsequently disrupting the bacterial membrane. The recently identified plasmid-encod...

Descripción completa

Detalles Bibliográficos
Autores principales: Stojanoski, Vlatko, Sankaran, Banumathi, Prasad, B. V. Venkataram, Poirel, Laurent, Nordmann, Patrice, Palzkill, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031297/
https://www.ncbi.nlm.nih.gov/pubmed/27655155
http://dx.doi.org/10.1186/s12915-016-0303-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031297/
https://www.ncbi.nlm.nih.gov/pubmed/27655155
http://dx.doi.org/10.1186/s12915-016-0303-0

Ejemplares similares